Back to search

Ireland· IE-PA-PA0540/150/002

Epilim Enteric 200 mg gastro-resistant coated tablets

A valproic acid product containing sodium valproate, registered in Ireland by Sanofi-Aventis Ireland Limited T/A SANOFI. The same ATC class is registered in 16 of our 19 countries.

ATC N03AG01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedEpilim Enteric 200 mg gastro-resistan…ATCN03AG01REGISTER NO.IE-PA-PA0540/150/002PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Valproic acid is registered in 16 of 19 countries.

Countries holding a registration under ATC N03AG01 (valproic acid), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 9 of them publish a price we can compare per daily dose

Valproic acid · ATC N03AG01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valproic acid costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Valproic acid · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Sodium valproate
Manufacturer
Sanofi-Aventis Ireland Limited T/A SANOFI
Country
Ireland (IE)
ATC code
N03AG01
ATC class
Valproic acid
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0540/150/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

391 interactions on record for valproic acid.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valproic acid · interactions on record

391 records

  • 9 severe
  • 132 moderate
  • 23 minor
  • 189 info

Most severe, free to view

  • Glycerol phenylbutyrateA16AX09severe
  • BexaroteneL01XF03severe
  • VorinostatL01XH01severe
  • BexarotenL01XX25severe

38 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valproic acid in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valproic acid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Convulex, Convulex Für Kinder
  • Belgium · Depakine, Depakine Enteric
  • Bulgaria · Convulex Chrono, Депакин
  • Cyprus · Depakine, Epixival
  • Czechia · Convulex, Convulex Cr
  • Germany · Ergenyl, Ergenyl Intravenös
  • Denmark · Delepsine, Delepsine Retard
  • Estonia · Convulex, Convulex Retard
  • Spain · Ácido Valproico Altan Pharmaceuticals, S.A., Acido Valproico Seacross
  • Finland · Absenor, Orfiril
  • France · Depakine, L.P.
  • United Kingdom (Northern Ireland) · Epilim, Episenta
  • Greece · Depakine, Hexaquin
  • Croatia · Convyval
  • Hungary · Convulex, Convulex Gyermekeknek
  • Iceland · Orfiril, Orfiril Retard
  • Italy · Acido Valproico Sandoz, Depakin
  • Lithuania · Convulex, Convulex Retard
  • Luxembourg · Depakine, Depakine Enteric
  • Latvia · Convulex, Convulex Retard
  • Malta · Epilim Liquid
  • Netherlands · Depakine Enteric, Depakine I.V.
  • Norway · Orfiril, Orfiril Long
  • Poland · Absenor, Convival Chrono
  • Portugal · Ácido Valpróico Generis, Depakine
  • Romania · Depakine, Orfiril Long
  • Sweden · Absenor, Absenor Depot
  • Slovenia · Convyval
  • Slovakia · Convulex, Convulex Cr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac7971a6-a8d9-4793-874a-1a6a8253223d
GET /v1/drugs/ac7971a6-a8d9-4793-874a-1a6a8253223d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gastro-resistant tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N03AG",
    "N03AG01"
  ],
  "strength": null,
  "pa_number": "PA0540/150/002",
  "substances": [
    "Sodium valproate"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "30/08/1983",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about valproic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.